1
|
Sakala I, Yankelevich WJ, Kjer-Nielsen L, Fairlie D, Rossjohn J, McCluskey J, Hoft D, Hansen T. How MAIT cells control the growth of intracellular mycobacteria (P4381). The Journal of Immunology 2013. [DOI: 10.4049/jimmunol.190.supp.183.26] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Abstract
Mucosal associated invariant T cells or MAIT cells have a semi-invariant TCR Vα chain and limited Vβ chains. In addition MAIT cell development is dependent upon the commensal microbiota and the expression of MR1, a highly conserved class Ib molecule of mammals. Mouse and human MAIT cells are activated in an MR1-restricted manner by cells infected with diverse strains for bacteria suggesting a widely shared antigen. Remarkably, human MR1 was recently shown to bind select bacterial vitamin B metabolites capable of activating MAIT cells in an MR1-restricted manner. This finding raised the interesting question of the importance of MR1 presentation of vitamin B metabolites for controlling bacterial infection. To address this question we have developed a mouse model whereby mycobacteria infected macrophages are co-cultured with purified MAIT cells, and control of intracellular bacterial growth is monitored. Using this assay, MAIT cell control of mycobacterial growth was found to depend upon IL-12 secretion by infected macrophages and IFN-γ secretion by MAIT cells. Interestingly, in the absence of infection, MAIT cells secreted IFN-γ in response to recombinant IL-12 alone or antigenic vitamin B metabolites. These findings demonstrate that MAIT cells can be activated by either TCR or non-TCR interactions. The contribution of these two pathways of MAIT cell activation in the context of mycobacterial infection is currently being investigated.
Collapse
Affiliation(s)
- Isaac Sakala
- 1Department of Pathology and Immunology, Washington Univ. Sch. of Med. In St. Louis, Saint Louis, MO
| | | | - Lars Kjer-Nielsen
- 3Department of Microbiology & Immunology, University of Melbourne, Melbourne, VIC, Australia
| | - David Fairlie
- 4Division of Chemistry & Structural Biology, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia
| | - Jamie Rossjohn
- 6Department of Biochemistry and Molecular Biology, Monash University School of Biomedical Sciences, Melbourne, VIC, Australia
- 7Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Monash University, Melbourne, VIC, Australia
- 8Institute of Infection and Immunity, Cardiff University, School of Medicine, Cardiff, United Kingdom
| | - James McCluskey
- 3Department of Microbiology & Immunology, University of Melbourne, Melbourne, VIC, Australia
| | - Daniel Hoft
- 5Divison of Infectious Diseases, Allergy & Immunology, Saint Louis University School of Medicine, Saint Louis, MO
- 9Departments of Internal Medicine & Molecular Microbiology, Saint Louis University School of Medicine, Saint Louis, MO
| | - Ted Hansen
- 1Department of Pathology and Immunology, Washington Univ. Sch. of Med. In St. Louis, Saint Louis, MO
| |
Collapse
|